Here you will find financial information related to Infant Bacterial Therapeutics AB.
The class B share of Infant Bacterial Therapeutics AB was listed on Nasdaq Stockholm First North on March 29, 2016 and approved to be listed on Nasdaq Stockholm from September 10, 2018.